This is a regulatory disclosure made by Elixir Capital Limited to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure pertains to two key actions approved by the company's Nomination and Remuneration Committee via a circular resolution passed on 16th June, 2026.

A. Allotment of Equity Shares from ESOP Exercise

  • The committee approved the allotment of 9,289 equity shares of face value ₹10 each.
  • This allotment was made pursuant to the exercise of 9,289 Employee Stock Options under the Elixir Capital Employee Stock Option Scheme – 2024.
  • Capital Structure Impact: The allotment increased the company's issued, subscribed, and paid-up share capital from ₹5,80,32,000 (consisting of 58,03,200 equity shares) to ₹5,81,24,890 (consisting of 58,12,489 equity shares).
  • The allotted shares will rank pari passu with the existing equity shares of the company.
  • The company is in the process of completing formalities for listing the allotted shares.

Annexure-A Details (Regulation 10(c) of SEBI SBEB&SE Regulations, 2021):

  • Company Registered Office: 58, Mittal Chambers, 228, Nariman Point, Mumbai City, Mumbai, Maharashtra-400021, India.
  • Listed Stock Exchange: BSE Limited.
  • Previous Statement Filing: A statement under Regulation 10(b) was filed with BSE Ltd. on 4th February, 2025 (Case no. 222802).
  • Scheme Title: Elixir Capital Employee Stock Option Scheme – 2024.
  • Security Type: Equity Shares.
  • Par Value: ₹10 per share.
  • Date of Issue: 16th June, 2026.
  • Number of Shares Issued: 9,289.
  • Distinctive Numbers: From 5803201 to 5812489 (inclusive).
  • Exercise Price: ₹10 per share.
  • Premium: Nil.
  • Total Shares Post-Issue: 58,12,489.
  • Total Capital Post-Issue: ₹5,81,24,890.
  • Lock-in: Not applicable.
  • Share Identicality: Yes, the shares are identical in all respects and rank pari-passu.
  • Listing Fees: Not applicable.

B. Grant of New Stock Options

  • The committee approved the grant of 71,180 new options under the same scheme.
  • Effective Grant Date: 16th June, 2026.
  • Each option is convertible into one equity share of face value ₹10.
  • Pricing Formula: The exercise price is fixed at ₹10 per option.
  • Vesting Period: A minimum of 1 year and a maximum of 4 years from the grant date.
  • Exercise Window: Vested options must be exercised within a maximum of 2 years from their respective vesting dates.
  • Potential Shares upon Full Exercise: If all 71,180 granted options are vested and exercised, they would result in an equivalent number of equity shares.
  • Options Lapsed: The document notes that 21,759 options have lapsed, though the context for this figure is not provided in the grant section.
  • Significant Terms: The scheme is administered by the Nomination and Remuneration Committee. It is implemented via a direct route (fresh allotment) for eligible employees based on defined criteria. The vesting schedule is at the committee's discretion and detailed in individual grant letters.